TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
About this item
Full title
Author / Creator
Publisher
Washington, DC: Endocrine Society
Journal title
Language
English
Formats
Publication information
Publisher
Washington, DC: Endocrine Society
Subjects
More information
Scope and Contents
Contents
ContextLittle is known about the frequency of key mutations in thyroid cancer metastases and its relationship with the primary tumor genotype.ObjectivesTo evaluate the frequency of TERT promoter (TERTp), BRAF, and NRAS mutations in metastatic thyroid carcinomas, analyzing primary thyroid tumors, lymph node metastases (LNMs), and distant metastases....
Alternative Titles
Full title
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1880084899
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1880084899
Other Identifiers
ISSN
0021-972X
E-ISSN
1945-7197
DOI
10.1210/jc.2016-2785
